期刊文献+

二母颗粒对小鼠Lewis肺癌模型的肿瘤血管生成的影响 被引量:3

The effect of Ermu particles on tumor angiogenesis in Lewis lung carcinoma bearing mice
原文传递
导出
摘要 目的观察二母颗粒对C57BL/6小鼠体内Lewis肺癌生长、转移以及血管生成的影响及其作用机制。方法制备C57BL/6小鼠Lewis肺癌模型,随机分为二母颗粒高、中、低(3、2、1 g.kg-1生药)剂量组、环磷酰胺组、沙利度胺组、模型组。分别给予相应药物后,观察各组小鼠的肿瘤生长情况及肺转移发生率,采用免疫组化方法观察瘤内血管内皮细胞生长因子(VEGF)和微血管密度(MVD)的表达。结果二母颗粒高、中、低剂量组连续ig给药14 d,对小鼠Lewis肺癌的抑瘤率分别为30.80%、10.63%、0。其中,二母颗粒高剂量组的瘤重、抑瘤率、VEGF及MVD的表达与模型组比较均有显著差异(P<0.05)。结论二母颗粒具有抑制小鼠Lewis肺癌的作用,其作用机制可能与抑制瘤内VEGF和MVD的生成有关。 OBJECTIVE To observe the effect of Ermu particles on the growth,metastasis and angiogenesis of C57BL/6 Lewis lung carcinoma bearing mice,and explore the corresponding mechanism.METHODS Lewis lung carcinoma bearing model was established in C57BL/6 mice.The model mice were stochastically divided into high dose(3 g·kg-1) Ermukeli particles group,middle dose(2 g·kg-1) Ermu particles group,low dose(1 g·kg-1) Ermu particlesi group,cyclophosphamide group,thalidomide group and model group.The growth condition of tumor and the rate of pulmonary metastasis were measured,and then the expression of vascular endothelial growth fator(VEGF) and microvessel density(MVD) in tumor were investigated by immunohistochemical staining.RESULTS On the basis of high,middle,low doses Ermu particles group treated by gavage for 14 d,the inhibition rates toward tumor were 30.80%,10.63% and 0%,respectively.The high dose Ermu particles group was significantly different from model group in terms of tumor weight,inhibitory rate,expression of VEGF and MVD(P0.05).CONCLUSION Ermu particles has the effect of inhibition toward C57BL/6 mice Lewis lung carcinomas,whose mechanism was related to inhibition toward generation of VEGF and MVD.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第6期650-652,共3页 West China Journal of Pharmaceutical Sciences
基金 国家十一五支撑计划重大项目(编号:2007BAI40B01) 四川省科技支撑计划(编号:2009SZ0052) 成都市十二五科技支撑项目(编号:11GGYB288SW-289)
关键词 二母颗粒 LEWIS肺癌 血管内皮细胞生长因子 微血管密度 作用机制 Ermu particles Lewis lung carcinoma Vascular endothelial growth fator(VEGF) Microvessel density(MVD):Mechanism
  • 相关文献

参考文献7

  • 1左衍海,施鑫.恶性肿瘤转移机制研究新进展[J].医学研究生学报,2008,21(3):293-297. 被引量:29
  • 2Giatrom A,Anolaki E. Angiogenes is in colorectal cancer:Prog-nostic and therapeutic in placations[ J]. Am J Clin Oncol,2006,29(4):408-417.
  • 3孙江涛,周清华,车国卫,朱文,王艳萍,张尚福,马力,朱大兴.非小细胞肺癌中VEGF表达、MVD值与临床病理特征相关性研究[J].山东医药,2006,46(19):44-45. 被引量:9
  • 4Uzzan B, Nicolas P, Cuchenil M, et al. Microvessd density as aprognostic factor in women with breast cancer : Asysieinatic reviewof the literature and meta - analysis [ J]. Cancer Res,2004,64(9):2941.
  • 5Shibuya M. Angiogenesis,anti - angiogenesis,and tumor suppres-sion[J]. Nippon Yakurigaku Zasshi,2002,120(5) :285 -294.
  • 6Byrne AM, Bouchier HDJ, Harmey JH. Angiogenic and cell sur-vival functions of vascular endothelial growth factor( VEGF) [ J].J Cell Mol Med,2005,9(4) :777 -794.
  • 7王丽娟,王岩,陈声武,马吉胜,付勤,王本祥.薯蓣皂苷元体内、外的抗肿瘤作用[J].中国中药杂志,2002,27(10):777-779. 被引量:104

二级参考文献30

  • 1夏欣一,吴永明,潘连军,金保方,黄宇烽,吴晓宇.恶性肿瘤DNA倍体异质性和临床生物学行为的关系[J].医学研究生学报,2007,20(3):272-274. 被引量:10
  • 2刘晓红,周晓军.Wnt-5a与肿瘤的研究进展[J].医学研究生学报,2007,20(7):759-762. 被引量:8
  • 3陈正堂.肿瘤分子靶向治疗的临床应用及其思考[J].医学研究生学报,2007,20(8):785-787. 被引量:27
  • 4Augustin HG.Antiangiogentic tumor therapy:will it work?Trends pharmcol Sci[J].1998,19:216-222.
  • 5Weidner G,Folkman J,Pozza F,et al.Tumor angiogenesis a nevi significant and independent prognostic indicator in earlystage breast carcinoma[J].Cancer Inst,1992,84:1875-1887.
  • 6Oreilly MS,Holmgren L,Shing Y,et al.Angiostatin:a znoel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma[J].Cell,1994,79:315.
  • 7Kraft A,Weindel K,Ochs A,et al.Vascular endothelia growth factor in the sera and effusions of patients with malignant and nonmalignant disease[J].Cancer,1999,85(1):178.
  • 8Yano S,Goto H,Yamamoto A,et al.Angiogenesis in the progression of lung cancer[J].Intern Med,2003,42 (3):305.
  • 9Ito H,Oshita F,Kameda Y,et al.Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas[J].Oncol Rep,2002,9(1):119-123.
  • 10Vasko VV ,Saji M. Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis[ J ]. Curr Opin Oncol, 2007,19(1) :11-17.

共引文献139

同被引文献28

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部